From Idea to Operating Business: Building a Regulated Healthcare Venture From Zero
How portfolio selection, regulatory sequencing and working capital planning converted a healthcare concept into an operating, fundable business.
Executive Mandate Summary
Key Transaction & Governance Challenges
- •The proposed business combined diagnostics and imaging, pharmacy retail and medical device distribution, but each vertical operated under different regulatory regimes, authorities, qualification conditions and timelines.
- •The initial wish list contained more than 50 activities. Each additional activity could introduce another regulator, qualified-person requirement, inspection and renewal obligation.
- •Seven approvals could not even be applied for until specific qualified individuals were in place, turning an apparent licensing programme into a recruitment programme.
- •The original assumption of a common opening date across all verticals was not supportable. Rent, salaries, shielding, layout work and equipment deposits would begin before approvals and revenue.
- •The inherited list included a licensing head that did not exist, omitted wholesale licensing and materially understated the timeline of a major activity.
Northrop Execution Architecture & Methodology
The Business Started With an Idea, Not a Licensing Question
The promoter arrived with a commercial premises, a capital plan and an ambition to build a broad healthcare business. The initial question appeared to be which licences were required. The actual question was more fundamental: which services should the business offer, what had to be true before each service could lawfully open, and how much capital would be consumed between the first filing and the first rupee of revenue?
That distinction changed the engagement from licence procurement into business design.
The Portfolio Was the First Strategic Decision
The opening wish list contained more than fifty activities across pathology, imaging, pharmacy retail and device distribution.
On paper, each additional activity represented potential revenue. From a regulatory perspective, however, each could introduce another regulator, qualified-person requirement, inspection and renewal obligation.
Northrop therefore tested each proposed activity against three variables: regulatory burden, time to first revenue and capital intensity.
The objective was not to maximise the number of services at launch. It was to define an opening portfolio that could actually be licensed, funded and operated.
The Critical Path Was a Hiring Plan
A major finding was that several approvals were not primarily filing problems.
Seven approvals required named, qualified individuals before applications could even proceed. These included a registered pharmacist, competent persons for relevant activities, a competent technical person for devices, an approved radiological safety officer, an equipment operator, a declared medical practitioner and a sonologist.
The regulatory programme therefore had to be rebuilt around recruitment dependencies.
What appeared to be an approval calendar was, in reality, a hiring calendar with filings attached.
The Licensing List Had to Be Rebuilt
The inherited working list contained material errors.
One licensing head did not exist. Another genuine licensing requirement, wholesale, had been omitted. Certain prescription-drug schedules had also been treated as separate licences even though the relevant obligations were compliance conditions attached to an existing retail licence.
Northrop removed the phantom requirements and introduced the wholesale licensing requirement subject to confirmation of the intended supply model.
The exercise demonstrated why regulatory planning cannot rely on circulated checklists alone. Each requirement must be tested against the relevant primary instrument or authority source.
Zero Fee Does Not Mean Zero Cost
The radiation safety workstream illustrated another critical issue.
The regulator’s licence and processing fees were nil, but compliance still required institutional and individual registration, dosimeter badges, appropriate radiological safety personnel, room-specific shielding layouts and quality assurance testing.
The programme therefore moved radiation-related work ahead of civil construction, separating the shielding and layout dependency from the licence application.
The broader lesson was clear: a fee schedule is not a cost model.
Working Capital Had to Follow the Regulatory Clock
Rent, statutory personnel salaries, shielding and layout work and equipment deposits began before the business generated revenue.
The original assumption of one common opening date across all verticals therefore could not support the funding plan.
Northrop rebuilt the programme around regulatory dependencies and translated that sequence into a working capital requirement covering the period from first filing to first revenue.
The capital requirement consequently reflected the regulatory reality rather than the business plan’s preferred opening date.
From Licence Inventory to Operating Model
The engagement ultimately moved the promoter from a broad concept to an operating business.
The final model incorporated a defined service portfolio, a verified approval map, a personnel dependency schedule, sequenced capital expenditure, a working capital plan and an ongoing compliance calendar.
The most important intervention was subtraction: deciding what the business would not do at launch reduced regulatory burden, shortened the working-capital period and supported earlier revenue generation.
Verifiable Institutional Outcomes & Value Realized
- The business moved from an expansive wish list to a defined opening portfolio with documented inclusion, deferral and exclusion decisions.
- A phased opening replaced the assumption of a single common opening date, allowing faster verticals to earn revenue while slower approvals progressed.
- The approval map identified governing laws, authorities, fees, processing timelines and conditions precedent.
- Regulated equipment procurement and installation were aligned with the order in which approvals, shielding, testing and operation could lawfully occur.
- Capital requirements were sized against the regulatory timeline rather than an optimistic business-plan opening date.
Ashish Chaudhary
Facing a Similar High-Stakes Transaction or Turnaround?
Northrop partners execute buy-side due diligence, fraud forensics, and financial restructuring with strict board confidentiality and unmatched technical rigor across Indian jurisdictions.
Case Study: Ghost Trainees and Unverified Placements in a Skill Development NGO
A skill development NGO reported that 1,200 youth had been trained and 840 placed in jobs under a programme funded through a ₹1.4 crore CSR contribution. The reported 70% placement rate prompted an independent review of beneficiary records, training delivery, placement claims and programme expenditure. Northrop Management Private Limited conducted a forensic verification covering beneficiary deduplication, attendance records, direct beneficiary calls, employer confirmations, offer letters, salary claims and the underlying financial trail.
View Full Mandate RecordNeed Guidance on Management Consulting?
Northrop senior partners advise boards, funds, and corporate leadership on high-stakes transactions, forensic audits, and regulatory compliance.